POREX TECHNOLOGIES CORP. – Trademark Portfolio
Entity Type: 03
POREX TECHNOLOGIES CORP. owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as POREX, MEDPOR, and SAV-IT. Of these, 4 are registered. The portfolio spans 5 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 9 (Computers & Electronics). Headquartered in FAIRBURN, GA.
500 BOHANNON ROAD
FAIRBURN, GA 30212
Showing of trademarks Trademarks
Trademark Classifications
POREX TECHNOLOGIES CORP.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does POREX TECHNOLOGIES CORP. have?
POREX TECHNOLOGIES CORP. has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 4 cancelled.
What trademark classes does POREX TECHNOLOGIES CORP. file in?
POREX TECHNOLOGIES CORP. files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 16 (Paper Goods), Class 17 (Rubber Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are POREX TECHNOLOGIES CORP.'s most well-known trademarks?
POREX TECHNOLOGIES CORP.'s registered trademark portfolio includes well-known marks such as POREX, MEDPOR, and SAV-IT. These are among 4 currently registered trademarks in the portfolio.
What is POREX TECHNOLOGIES CORP.'s trademark registration success rate?
POREX TECHNOLOGIES CORP. has a 44% trademark registration rate, with 4 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.